India's first indigenous Covid-19 vaccine (BBV152 COVID vaccine) may be launched by August 15. The Indian Council of Medical Research (ICMR) has written to select medical institutions and hospitals to fast-track clinical trial approvals for the vaccine. The ICMR said that it is envisaged to launch the vaccine for public health use latest by August 15, after completion of all clinical trials.

ICMR has partnered with Bharat Biotech International Limited (BBIL) for clinical trials of indigenous vaccine 'Covaxin' for the coronavirus disease.

The indigenous, inactivated vaccine was developed and manufactured in Bharat Biotech’s facility located in Genome Valley in Hyderabad. Bharat Biotech India Ltd’s covid-19 vaccine ‘Covaxin’ has become the first candidate developed in India to receive the Drug Controller General of India’s approval to enter human trials.

India targets to launch Covid-19 vaccine by August 15